Setup News Ticker
Searching for 'Business Company'. (Return)

MarketWatch MarketPulseAug 06, 2020
UPDATE: Bausch Health shares soar 27% premarket after confirming to spin off eye-care business
Bausch Health Cos. shares soared 27% in premarket trade Thursday, after the company said it is planning to spin off its eye-care business into a separate public company, confirming a Wall Street Journal report. The business, known as Bausch & Lomb, accounted for nearly half of the company's $8.6 billion in revenue last year, the WSJ reported. Bausch said the move will allow it to focus on expanding its position in GI, aesthetics and dermatology, neurology and international pharma. The company said it will complete the spinoff in stages, and will start by reporting Bausch & Lomb as a separate segment starting in the first quarter of 2021. Timing of the spinoff will then depend on a range of factors, including regulatory approvals. The move further breaks apart the former Valeant, which acquired Bausch & Lomb for $8.7 billion in 2013, under then-CEO Michael Pearson. Under Pearson, Valeant had used acquisitions to aggressively grow and become a popular stock, until the company was caught up in a series of drug pricing and accounting scandals. Shares have fallen 35% in the year through Wednesday, while the S&P 500 has gained 3%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit for more information on this news.

Bausch Health shares soar 23% premarket on report to spin off eye-care business (MarketWatch MarketPulse)

MarketWatch MarketPulseAug 06, 2020
Mylan swings to profit as sales fall slightly short of estimates
Mylan N.V. said Thursday it had net income of $39.4 million, or 8 cents a share, in the second quarter, after a loss of $168.5 million, or 33 cents a share, in the year-earlier period. The company said its adjusted net income came to $574.3 million compared with 532.8 million a year ago, but did not offer an adjusted per-share figure. Revenue fell to $2.731 billion from $2.852 billion. The FactSet consensus was for EPS of 99 cents and revenue of $2.735 billion. "We now expect the overall COVID-19 recovery efforts will occur slower than anticipated and may continue throughout the rest of the year," the company said in a statement. "As a result, we expect total revenues, which absorbed a 2% net decline related to COVID-19 in the first half of the year, to have an overall similar negative impact for the second half of the year." Mylan now expects full-year revenue to range from $11.5 to $12.0 billion. The company is expecting the acquisition of Pfizer's Upjohn business to be completed in the fourth quarter. Shares were slightly higher premarket, but have fallen 16% in the year to date, while the S&P 500 has gained 3%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit for more information on this news.

CoronavirusTrump vaccine deal million latest
marketstock vaccine updates premarket Dow
Stockmarket earnings Gold futures higher
Millionclaims Coronavirus Jobless pandemic vaccine
TrumpFacebook coronavirus Post Twitter Biden
Pandemicmillion coronavirus Profit COVID-19 during
COVID-19Vaccine How Facebook Trump pandemic
FilerINC 8-K 10-Q Corp Fund
TikTokReels Instagram Microsoft Facebook Deal
claimsJobless million Stock Weekly futures

Top News (Business News)
Accounting Today
AdWeek News
Banking Business Review
Barron's This Week Magazine
Barron's Up and Down Wall Street Daily
Brad Ideas
Chicago Tribune Business News
CNBC Business
CNBC Economy
CNBC Finance
CNN/Money Real Estate News Analysis Indicators
Enterprise Application News
Forbes Headlines
Forbes Social Media News - China, Economy & Trade - Financial Markets - Hedge Funds - Telecoms - US
Google Business News
Google Market News
HBS Working Knowledge
INSEAD Knowledge
International Tax Review
L.S. Starrett News
MarketWatch Breaking News
MarketWatch MarketPulse
McKinsey Quarterly Business
Nielsen Trends
NonProfit Times
NPR Topics: Business
NYTimes Business
Private Equity Breaking News
Reuters Business
Reuters Company News
Reuters Money Updates: News Digest
Tax Policy News
The Economist International News
The Motley Fool
USA Today Money
Wall Street Journal US Business
Wall Street Transcript
Washington Post Business
WSJ Asia
WSJ Europe
WSJ MoneyBeat
WSJ Opinion
WSJ World Markets
Yahoo Business
  • CEOExpress
  • 1 Boston Place | Suite 2600
    Boston MA 02108
  • 617 482 1200
    617 299 8649 (fax)
  • Contact
  • As an Amazon Associate
    CEOExpress earns from
    qualifying purchases.

©1999-2020 CEOExpress Company LLC